Pasterkamp G - Search Results

1

TGF-β1 content in atherosclerotic plaques, TGF-β1 serum concentrations and incident coronary events.

Herder C, Peeters W, Zierer A, de Kleijn DP, Moll FL, Karakas M, Roden M, Meisinger C, Thorand B, Pasterkamp G, Koenig W. Herder C, et al. Among authors: pasterkamp g. Eur J Clin Invest. 2012 Mar;42(3):329-37. doi: 10.1111/j.1365-2362.2011.02587.x. Epub 2011 Sep 23. Eur J Clin Invest. 2012. PMID: 21950567

2

Morphometric and immunohistochemical characterization of the intimal layer throughout the arterial system of elderly humans.

Vink A, Schoneveld AH, Poppen M, de Kleijn DP, Borst C, Pasterkamp G. Vink A, et al. Among authors: pasterkamp g. J Anat. 2002 Jan;200(Pt 1):97-103. doi: 10.1046/j.0021-8782.2001.00005.x. J Anat. 2002. PMID: 11837253 Free PMC article.

3

Significance of peptidoglycan, a proinflammatory bacterial antigen in atherosclerotic arteries and its association with vulnerable plaques.

Laman JD, Schoneveld AH, Moll FL, van Meurs M, Pasterkamp G. Laman JD, et al. Among authors: pasterkamp g. Am J Cardiol. 2002 Jul 15;90(2):119-23. doi: 10.1016/s0002-9149(02)02432-3. Am J Cardiol. 2002. PMID: 12106839

4

MMP inhibition and lumen loss after balloon angioplasty or stenting.

Pasterkamp G, Sierevogel MJ, de Kleijn DP, Strauss BH. Pasterkamp G, et al. Arterioscler Thromb Vasc Biol. 2002 Jul 1;22(7):1241; author reply 1241. doi: 10.1161/01.atv.0000023563.01512.1e. Arterioscler Thromb Vasc Biol. 2002. PMID: 12117746 No abstract available.

5

[Remodelling of the arterial wall: a determinant of luminal stenosis and a factor with prognostic significance].

Vink A, de Kleijn DP, Borst C, Pasterkamp G. Vink A, et al. Among authors: pasterkamp g. Ned Tijdschr Geneeskd. 2002 Jul 6;146(27):1264-70. Ned Tijdschr Geneeskd. 2002. PMID: 12138670 Review. Dutch.

6

Atherosclerotic expansive remodeled plaques: a wolf in sheep's clothing.

Pasterkamp G, Fitzgerald PF, de Kleijn DP. Pasterkamp G, et al. J Vasc Res. 2002 Nov-Dec;39(6):514-23. doi: 10.1159/000067204. J Vasc Res. 2002. PMID: 12566977 Review.

7

Matrix metalloproteinases: a therapeutic target in cardiovascular disease.

Sierevogel MJ, Pasterkamp G, de Kleijn DP, Strauss BH. Sierevogel MJ, et al. Among authors: pasterkamp g. Curr Pharm Des. 2003;9(13):1033-40. doi: 10.2174/1381612033455099. Curr Pharm Des. 2003. PMID: 12678855 Review.

8

Toll-like receptors in cardiovascular diseases.

de Kleijn D, Pasterkamp G. de Kleijn D, et al. Among authors: pasterkamp g. Cardiovasc Res. 2003 Oct 15;60(1):58-67. doi: 10.1016/s0008-6363(03)00348-1. Cardiovasc Res. 2003. PMID: 14522407 Review.

9

Expansive arterial remodeling: location, location, location.

Pasterkamp G, Galis ZS, de Kleijn DP. Pasterkamp G, et al. Arterioscler Thromb Vasc Biol. 2004 Apr;24(4):650-7. doi: 10.1161/01.ATV.0000120376.09047.fe. Epub 2004 Feb 5. Arterioscler Thromb Vasc Biol. 2004. PMID: 14764423 Free PMC article. Review.

10

IgM antibody level against proinflammatory bacterial peptidoglycan is inversely correlated with extent of atherosclerotic disease.

Nijhuis MM, van der Graaf Y, Melief MJ, Schoneveld AH, de Kleijn DP, Laman JD, Pasterkamp G; SMART Studygroup. Nijhuis MM, et al. Among authors: pasterkamp g. Atherosclerosis. 2004 Apr;173(2):245-51. doi: 10.1016/j.atherosclerosis.2003.12.005. Atherosclerosis. 2004. PMID: 15064098 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

599 results

Search Page

Filters